Baker Brothers Advisors - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2021$2,434,000
-81.1%
104,521
-74.7%
0.01%
-78.9%
Q3 2021$12,869,000
-11.3%
412,4660.0%0.06%
-10.9%
Q2 2021$14,511,000
-0.2%
412,4660.0%0.06%
+1.6%
Q1 2021$14,539,000
-6.0%
412,4660.0%0.06%
+8.6%
Q4 2020$15,472,000
-15.6%
412,466
-24.9%
0.06%
-20.5%
Q3 2020$18,322,000
+87.4%
549,047
+48.8%
0.07%
+69.8%
Q2 2020$9,776,000
+61.8%
369,0470.0%0.04%
+16.2%
Q1 2020$6,041,000
-4.9%
369,047
+47.6%
0.04%
+8.8%
Q4 2019$6,355,000
+27.1%
250,0000.0%0.03%0.0%
Q3 2019$5,000,000
-38.0%
250,0000.0%0.03%
-38.2%
Q2 2019$8,060,000
+0.1%
250,0000.0%0.06%
+5.8%
Q1 2019$8,053,000
+31.3%
250,0000.0%0.05%
+4.0%
Q4 2018$6,133,000
-25.6%
250,0000.0%0.05%
-7.4%
Q3 2018$8,240,000
-7.2%
250,0000.0%0.05%
-19.4%
Q2 2018$8,875,000
+9.0%
250,0000.0%0.07%
-2.9%
Q1 2018$8,143,000
+59.0%
250,000
+25.0%
0.07%
+56.8%
Q4 2017$5,120,000
+22.2%
200,0000.0%0.04%
+29.4%
Q3 2017$4,190,000
+1.7%
200,0000.0%0.03%
-5.6%
Q2 2017$4,120,000200,0000.04%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Prosight Management, LP 480,000$14,318,0009.25%
Decheng Capital Management III (Cayman), LLC 518,342$15,462,0004.74%
TANG CAPITAL MANAGEMENT LLC 467,702$13,952,0002.79%
Birchview Capital, LP 113,000$3,371,0002.43%
Privium Fund Management B.V. 351,805$10,494,0002.32%
Sio Capital Management, LLC 144,546$4,312,0001.43%
Perceptive Advisors 2,360,139$70,403,0001.41%
Chicago Capital, LLC 1,011,744$30,180,0001.30%
Endurant Capital Management LP 120,834$3,604,0000.95%
Nicholas Investment Partners, LP 439,235$13,102,0000.93%
View complete list of ALBIREO PHARMA INC shareholders